Eosinophilic pneumonia: a case of daptomycin induced lung injury

被引:5
作者
Raman, Vaishnavi
Chaudhary, Isha [1 ]
Shieh, Sean
机构
[1] Saba Univ, Sch Med, Church St, Saba, Dutch Caribbean, Netherlands
关键词
Daptomycin; pulmonary eosinophilia; adverse drug event; respiratory insufficiency;
D O I
10.1080/20009666.2021.1883813
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Eosinophilic pneumonia is a category of lung diseases characterized by an increased number of eosinophils in alveolar spaces and interstitium. Acute cases are often caused by fungal infections, parasites, drugs or toxins and can present with respiratory failure. Daptomycin has been identified as one of the rare causes of acute eosinophilic pneumonia. We describe a case of an elderly man on daptomycin for MRSA endocarditis treatment who presented to the hospital with fevers and dyspnea within two weeks of daptomycin initiation. As an inpatient, he developed an increasing oxygen requirement necessitating intensive care unit management. Daptomycin cessation improved his symptoms and he was placed on a steroid taper. These findings suggested a diagnosis of daptomycin-induced eosinophilic pneumonia. However, the patient deteriorated and eventually passed away despite resuscitative efforts. This case highlights the importance of prompt identification of eosinophilic pneumonia, its potential severity and the need for more exploration regarding the timing of corticosteroid taper. This in turn will inform more effective approaches to this condition in the future.
引用
收藏
页码:280 / 285
页数:6
相关论文
共 14 条
[1]  
[Anonymous], 2010, FDA drug safety communication: Safety update for osteoporosis drugs, bisphosphonates, and atypical fractures
[2]   Drug-induced eosinophilic pneumonia A review of 196 case reports [J].
Bartal, Carmi ;
Sagy, Iftach ;
Barski, Leonid .
MEDICINE, 2018, 97 (04)
[3]  
Belotero Balance, 2010, Package insert
[4]   Eosinophilic Lung Diseases [J].
Cottin, Vincent .
CLINICS IN CHEST MEDICINE, 2016, 37 (03) :535-556
[5]   Acute Eosinophilic Pneumonia Causes, Diagnosis, and Management [J].
De Giacomi, Federica ;
Vassallo, Robert ;
Yi, Eunhee S. ;
Ryu, Jay H. .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2018, 197 (06) :728-736
[6]   Daptomycin [J].
Heidary, Mohsen ;
Khosravi, Azar Dohkt ;
Khoshnood, Saeed ;
Nasiri, Mohammad Javad ;
Soleimani, Saleh ;
Goudarzi, Mehdi .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2018, 73 (01) :1-11
[7]   Daptomycin-induced Eosinophilic Pneumonia and a Review of the Published Literature [J].
Higashi, Yoshitsugu ;
Nakamura, Shigeki ;
Tsuji, Yasuhiro ;
Ogami, Chika ;
Matsumoto, Kaoru ;
Kawago, Koyomi ;
Tokui, Kotaro ;
Hayashi, Ryuji ;
Sakamaki, Ippei ;
Yamamoto, Yoshihiro .
INTERNAL MEDICINE, 2018, 57 (02) :253-258
[8]   Eosinophilic Pneumonia in Patients Treated with Daptomycin Review of the Literature and US FDA Adverse Event Reporting System Reports [J].
Kim, Peter W. ;
Sorbello, Alfred F. ;
Wassel, Ronald T. ;
Pham, Tracy M. ;
Tonning, Joseph M. ;
Nambiar, Sumathi .
DRUG SAFETY, 2012, 35 (06) :447-457
[9]   Two Cases of Daptomycin-Induced Eosinophilic Pneumonia and Chronic Pneumonitis [J].
Lal, Yasir ;
Assimacopoulos, Aristides P. .
CLINICAL INFECTIOUS DISEASES, 2010, 50 (05) :737-740
[10]  
Patel Jayshil J, 2014, WMJ, V113, P199